Approvals, trial readouts, recall alerts and market moves — verified trade news for hospital, clinic and global procurement teams.
MaxQ Medical has closed a $31.5m Series A round. The funding will push the MaxQ Medical prostate platform toward broader…
Rebecca Miles
Researchers at the University of Illinois Urbana-Champaign have built a new Beacon dialysis wearable. The device targets…
Read more
The Samsung Galaxy Buds hearing aid feature has landed US Food and Drug Administration (FDA) clearance.
Read more
A new exploratory randomized controlled trial in the journal Nutrients has flagged a possible benefit of tomatoes on hep…
Read moreThe FDA has cleared Freenome's SimpleScreen CRC blood test. It is a new screening option for average-risk adults. The ap…
Read more
New TESLA trial thrombectomy data show a 1-year benefit for large-core acute ischemic stroke patients. That holds even t…
Read more
New ACP obesity guidelines name semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) as first-line drugs. …
Read more
A new hantavirus cruise ship outbreak on the MV Hondius has hit 13 cases and 3 deaths as of May 27, 2026. Labs confirmed…
Read more
A new look at GLP-1 oral side effects shows "Ozempic mouth" is more than a tabloid label. Dentists track dry mouth, hali…
Read more
A new psilocybin dementia case from Brazil describes major symptom relief in an 80-year-old woman with advanced Alzheime…
Read more
A new ER-100 epigenetic therapy from Life Biosciences has reached its first human patient. The Boston-based biotech has …
Read more
A new look at BPH herbal remedies finds that plant-based options ease mild LUTS. But gains stay modest. Evidence stays p…
Read more
A new HDV-LIS T1D trial readout from OPTI-2 shows a liver-targeted fast-acting insulin cut hypoglycemia risk in type 1 d…
Read more